Cullinan Oncology Inc logo

Cullinan Oncology Inc

NAS:CGEM (USA)   Ordinary Shares
$ 9.05 -0.64 (-6.6%) 11:08 PM EST
P/E:
At Loss
P/B:
0.77
Market Cap:
$ 386.75M
Enterprise V:
$ -98.78M
Volume:
95.43K
Avg Vol (2M):
175.28K
Volume:
95.43K
Market Cap $:
386.75M
PE Ratio:
At Loss
Avg Vol (2M):
175.28K
Enterprise Value $:
-98.78M
PB Ratio:
0.77

Business Description

Cullinan Oncology Inc logo
Cullinan Oncology Inc
NAICS : 541713 SIC : 2834

Share Class Description:

CGEM: Ordinary Shares
Description
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
Name Current Vs Industry Vs History
Cash-To-Debt 78.42
Equity-to-Asset 0.96
Debt-to-Equity 0.01
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -13.4
3-Year FCF Growth Rate -14.5

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 26.07
9-Day RSI 32.49
14-Day RSI 36.32
6-1 Month Momentum % 1.3
12-1 Month Momentum % -12.38

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 25.32
Quick Ratio 25.32
Cash Ratio 24.99

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -58.7
Shareholder Yield % -0.89

Financials (Next Earnings Date:2023-11-14 Est.)

CGEM's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CGEM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Cullinan Oncology Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.37
Beta 0
Volatility % 24.08
14-Day RSI 36.32
14-Day ATR ($) 0.53957
20-Day SMA ($) 10.1085
12-1 Month Momentum % -12.38
52-Week Range ($) 7.782 - 13.985
Shares Outstanding (Mil) 42.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cullinan Oncology Inc Filings

Filing Date Document Date Form
No Filing Data

Cullinan Oncology Inc Stock Events

Event Date Price($)
No Event Data

Cullinan Oncology Inc Frequently Asked Questions

What is Cullinan Oncology Inc(CGEM)'s stock price today?
The current price of CGEM is $9.05. The 52 week high of CGEM is $13.99 and 52 week low is $7.78.
When is next earnings date of Cullinan Oncology Inc(CGEM)?
The next earnings date of Cullinan Oncology Inc(CGEM) is 2023-11-14 Est..
Does Cullinan Oncology Inc(CGEM) pay dividends? If so, how much?
Cullinan Oncology Inc(CGEM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1